We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Scapa Group Plc | LSE:SCPA | London | Ordinary Share | GB0007281198 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 214.50 | 214.50 | 215.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
09/4/2020 13:03 | Dipped my toe in for a couple of thousand. | outfly | |
08/4/2020 15:03 | Looks like that today, all automated trades.........shoul Trade time Trade price Trade quantity Buy/Sell Bid price Ask price 08 Apr 14:57:20 105.60 433 Sell 105.60 106.20 08 Apr 14:56:20 106.20 121 Sell 106.20 106.80 08 Apr 14:56:20 106.20 555 Sell 106.20 106.80 08 Apr 14:56:20 106.20 361 Sell 106.20 106.80 08 Apr 14:56:20 106.20 931 Sell 106.20 106.80 08 Apr 14:56:20 106.20 1,181 Sell 106.20 106.80 08 Apr 14:56:20 106.20 1,581 Sell 106.20 106.80 08 Apr 14:56:08 106.35 964 Sell 106.20 107.20 08 Apr 14:39:20 107.11 15,000 Buy 106.40 107.20 08 Apr 14:37:58 106.80 1,223 Sell 106.80 107.40 08 Apr 14:37:58 106.80 252 Sell 106.80 107.40 08 Apr 14:37:58 106.80 385 Sell 106.80 107.40 08 Apr 14:37:58 106.80 421 Sell 106.80 107.40 08 Apr 14:37:56 107.00 1,136 Sell 107.00 107.60 08 Apr 14:37:56 107.00 168 Sell 107.00 107.60 08 Apr 14:37:56 107.40 970 Buy 106.80 107.40 08 Apr 14:37:56 107.00 5,609 Sell 107.00 107.60 08 Apr 14:37:56 107.00 394 Sell 107.00 107.60 | 3rd eye | |
06/4/2020 20:11 | Wonder who and how many more left to go | marmar80 | |
06/4/2020 17:04 | Must be some forced seller in the background | marmar80 | |
06/4/2020 17:03 | Robbed at the end of the day and not just on this one. MMs taking the P. | 3rd eye | |
06/4/2020 13:41 | Further to the previous post, stock can't even hold a small bounce at the moment. There are far too many sellers in size from 110 all the way to 115 at the moment. | sphere25 | |
06/4/2020 13:19 | Lifted from IG B/Board..... Scapa - Factories “essential business” status 108p Epic code: SCPA (Sharewatch) • I have been watching Scapa (SCPA; 108p) for a re-entry point for some time. First time round on SCSW we did very well, tipping the shares in Nov‘11 at 47p and selling at 355p in Dec.’18. Back in 2011, Scapa’s mainstay was industrial tape. These are tapes based on silicon, acrylic or other materials and fall into a range of applications where there is a need to attach, identify or protect something. Scapa’s portfolio ranges from masking tape, tape for identification of electrical wiring right through to tape for sticking a Peugeot badge on the grill of a car; tapes are usually sold under the brand of its OEM. In 2008 the business came unstuck in the credit crunch nastiness. Almost overnight, when houses stopped being built and cars stopped selling, Scapa's distributors began to destock and against the background of a bloated cost base, debts ballooning and a large pension deficit, Scapa could easily have disappeared into the mists of time. But it survived and under chief executive Heejae Chae, an old Volex-hand, Scapa was radically reshaped. Costs were cut and disposals of non-core parts made and Chae’s cool head approach was to transition the business into the higher margin and higher growth medical sector. The products that Scapa targeted were based on silicon gel eg. disposable adhesive pads for medical devices such as heart monitors that are attached to patients; transdermal patches, which slowly release drugs through the skin; and also advanced woundcare, making sheeting for plasters. Chae’s insight was to target turnkey or one-stop-shop packaged contracts, which landed big multi-year parcels of work. This culminated in three technology transfers of manufacturing assets. The biggest was Systagenix’s site in Yorkshire for £31.4m in 2018. It brought in a team of R&D scientists, a new microbiology lab and a dedicated gamma sterilisation facility. But the deal pushed a rival’s nose out of joint (ConvaTec) causing it to abandon its own US$30m contract with Scapa. Scapa reacted by cutting its labour outgoings in a bid to mitigate the fallout and Chae reversed his earlier decision to retire in order to put out the fire. Scapa says it did no wrong and has filed for damages of US$83.8m . On Numis’ forecast eps of 13.2p for the year just ended (Scapa says it has met forecasts) and 15.1p for the year started 1 April, the PE falls to 7.2, which is not demanding for a medtech outsourcer. All Scapa’s sites have been assigned “essential business” status, which means they are up and running. Maybe some sites could be repurposed to make masks. I don’t know when but somewhere up ahead there will be a big buy opportunity. | 3rd eye | |
06/4/2020 13:13 | They don't produce face masks | marmar80 | |
06/4/2020 13:12 | What masks? | marmar80 | |
06/4/2020 11:52 | Quite high demand for masks | tjbird | |
06/4/2020 10:18 | Looks good for 230 | onjohn | |
06/4/2020 09:26 | I've dipped a toe in at these levels this morning | tole | |
06/4/2020 09:00 | SCPA starting to move up now. | 3rd eye | |
06/4/2020 08:33 | rns on 27th Our Healthcare sites have been assigned "essential business" status in the US and UK and our Industrial sites are similarly deemed essential manufacturing by these respective governments. As of 26 March 2020, all Scapa sites are operating, with the exception of India, which has been temporarily closed pursuant to Government mandate. | tjbird | |
31/3/2020 15:34 | Been nibbling a few here. That's a very good statement in this environment. The market knows the theme now and with the brutal re-ratings of many stocks (with fear, panic and forced selling galore), the market is now rallying on bad news for many stocks out there. Clearly that doesn't mean throw everything at the markets - still have to exercise caution. Plenty of sales on but plenty of bumps to come before the recovery. There is a significant amount of buying coming in today too which is encouraging and this one could bounce nicely from these levels. | sphere25 | |
27/3/2020 08:56 | What do people make of the news today? Seems reassuring but with fingers crossed? Good to see their plants are operating | ayl30 | |
18/3/2020 20:43 | 3rd day in a row that share price has risen noticeably towards the end of the day....hmmmm | grim | |
18/3/2020 17:48 | I was too greedy. I had set a buy limit order for 15k @ 92p on Monday's fall. One that got away. | outsizeclothes.com | |
17/3/2020 10:45 | Stock has bounced up over 120. Just lobbed half at 120.8. Will let the rest run with a tight stop. Keep it safe and controlled out there folks. Dangerous times with mass liquidations and algos seemingly out of control with noone at the wheel at times. Closing auction update: Stock has closed up 7.3% at 129p. I have sold the remainder into the rise. No confidence on whether the DOW opens up 1000 or down 2000 tomorrow so play it safe. | sphere25 | |
17/3/2020 09:47 | I've just nipped in for a few here at 111.8p. Yesterday's price action was notable as mentioned by grim. It is moving somewhat peculiar. It might just be an oversold bounce or larger buyers sensing value. Unsure if it is anything more than that, but at worst, it's another quick short term trade. Not easy to trade the long side in this market and still have to be careful to be disciplined - if it goes wrong, exit. The volatility and fear out there means prices can shoot either way 10% in a flash. | sphere25 | |
16/3/2020 20:31 | Interesting share price action today. Fell on open from 107p to 95p & then at 2pm ish it turned around & increased to 120p.This on a day when almost all other sp's fell. | grim | |
13/3/2020 14:26 | Personally I think it's overdone. Unless there's more than a 10 week shutdown of activity globally, a year from now earnings will have fully recovered. | outsizeclothes.com |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions